Skip to main content
MedVellum
MCQsExamsAtlas
DashboardPricing
MBBS / Core medicine✳Dermatology✳ICU Fellowship (CICM)✳Anaesthesia✳Emergency Medicine✳Psychiatry Fellowship✳Paediatrics Fellowship✳Physician Medicine✳MCQs✳SAQs✳Vivas✳OSCE✳Evidence-first✳MBBS / Core medicine✳Dermatology✳ICU Fellowship (CICM)✳Anaesthesia✳Emergency Medicine✳Psychiatry Fellowship✳Paediatrics Fellowship✳Physician Medicine✳MCQs✳SAQs✳Vivas✳OSCE✳Evidence-first✳

MedVellum.

The folio

Exam-exhaustive medical education across every specialty — evidence-graded topics, engraved plates, and practice in every written and oral format. Educational content only — not medical advice.

llms.txt · psychiatry LLM catalog · sitemap

Atlas

  • Specialty atlas
  • MBBS / Core medicine
  • Dermatology
  • ICU Fellowship (CICM)
  • Anaesthesia
  • Emergency Medicine
  • Psychiatry Fellowship
  • Paediatrics Fellowship
  • Physician Medicine

Study & account

  • MCQ practice
  • Practice alias
  • Exam tools
  • Dashboard
  • Pricing
  • Sign in

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

Folio edition · Set in Instrument Serif & Archivo

Phys Clinical Casesoncological

Phys Clinical Cases · oncological

Cancer Cachexia AND Nutritional Support — DCE Clinical Case

DCE long-case and short-case station for Cancer Cachexia AND Nutritional Support.

On this page & tools

Target exams

FRACP DCEMRCP PACES

Target exams

FRACP DCEMRCP PACES
Prompt
DCE long-case and short-case station for Cancer Cachexia AND Nutritional Support.

Cancer Cachexia AND Nutritional Support — Clinical Case

DCE Long Case

Patient brief

Patient: A middle-aged or older adult with multimorbidity and a presentation centred on Cancer Cachexia AND Nutritional Support. [1]

Presenting complaint: Subacute or acute symptoms referable to Cancer Cachexia AND Nutritional Support, with enough detail to force prioritisation. [1] [2]

Past history: Common cardiometabolic and organ comorbidities that interact with the plan. [2]

Medications: A polypharmacy list that includes at least one interaction or dosing issue. [2]

Examination: Key positives and critical negatives for dangerous differentials. [1]

Investigations: A small set of results that change management. [1] [2]

Tasks

  1. Present a prioritised problem list. [1]
  2. Defend investigations and immediate therapy. [1] [2]
  3. Provide safety-net and follow-up advice. [2]

Model discussion points

  • Working diagnosis and acuity. [1]
  • Differentials and discriminators. [2]
  • Treatment sequence and monitoring. [1] [2] [3]
  • Multimorbidity and communication. [2]

Short case

Focused examination or counselling station linked to Cancer Cachexia AND Nutritional Support, with one interpretation task and one shared-decision point. [1] [2]

References

  1. [1]Liu TK, Noble D, Stares M, Phillips I Identifying markers of cachexia and nutritional deficit on radical radiotherapy outcomes in lung and head and neck cancer Curr Opin Support Palliat Care, 2026.PMID 42421369
  2. [2]Petersen E, Sheldon J, Torgerson H, Kirschenbaum M, et al. The impact of cachexia and sarcopenia in bladder cancer Curr Opin Support Palliat Care, 2026.PMID 42417054
  3. [3]Monnery D, Collins J, Droney J Practical prescribing in cancer cachexia Curr Opin Support Palliat Care, 2026.PMID 42411339
  4. [4]Shen S, Zhou K, Wu M, Liu D, et al. Feeding intelligence: comparative evaluation of ChatGPT and clinical guidelines for nutritional management in head and neck cancer J Transl Med, 2025.PMID 41272713
  5. [5]Muscaritoli M, Molfino A, Orlando S, Tambaro F Advancements of investigational agents for cancer cachexia: what clinical progress have we seen in the last 5 years? Expert Opin Investig Drugs, 2025.PMID 41222020
  6. [6]Hustad KS, Kaasa S, Laird BJA Integrated nutritional care in cancer; about time? Curr Opin Support Palliat Care, 2025.PMID 40689650
  7. [7]Xi Y, Yao T, Zhang C, Zhuang T Effectiveness of safety care and clinical nursing pathway in patients undergoing cardiovascular intervention: a randomized controlled trial Perioper Med (Lond), 2026.PMID 42469924
  8. [8]Marks FJ, Walters SJ, Sutton L, Jacques RM What statistical methods are more appropriate for predicting recruitment at the design stage of a randomised controlled trial? Trials, 2026.PMID 42469922